Related Experiment Video
Updated: Jul 5, 2025

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
Apple Pomace Extract Improves MK-801-Induced Memory Impairment in Mice
Ayako Watanabe1,2, Minori Shimada1, Hayato Maeda1,2
1Department of Applied Biology and Food Sciences, Faculty of Agriculture and Life Science, Hirosaki University, 3 Bunkyo-cho, Hirosaki 036-8561, Japan.
Apple pomace extract may help prevent and treat Alzheimer's disease (AD). Studies show it reversed memory impairment in mice by affecting genes related to brain synapses and neurotransmission.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Alzheimer's disease (AD) is a neurodegenerative condition characterized by cognitive decline, synaptic damage, and neurotransmission issues.
- Apple pomace, an apple industry byproduct, shows potential health benefits, but its effects on AD are unexplored.
Purpose of the Study:
- To investigate the potential of apple pomace extract in preventing and treating Alzheimer's disease-like memory deficits.
- To explore the molecular mechanisms underlying apple pomace extract's effects on the brain.
Main Methods:
- Administered apple pomace extract to mice for 7 days to assess its impact on MK-801-induced memory impairment.
- Utilized RNA sequencing and real-time PCR to analyze gene expression changes in the mouse hippocampus.
Main Results:
- Apple pomace extract treatment reversed memory impairments in associative and recognition tasks induced by MK-801.
- Gene expression analysis revealed upregulation of Zfp125 and Gstp1 mRNA.
- Upregulation of gene sets associated with synaptic function and neurotransmission was observed in the hippocampus.
Conclusions:
- Apple pomace extract demonstrates neuroprotective effects against memory deficits.
- The extract's therapeutic potential for Alzheimer's disease may stem from its ability to modulate synaptic and neurotransmission pathways.
More Related Videos
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018